Brilinta Has Advantages Over Plavix for Heart
Study Shows Blood Thinner Brilinta May Be Effective in Patients With a Genetic Variant
Gene Variants and Plavix
Other research presented at the meeting seems to contradict previous findings, suggesting that the presence of these variants does not influence outcomes among patients on Plavix after all.
To assess the influence genetics might have on patients prescribed Plavix, Guillaume Paré, MD, and colleagues from McMaster University looked at 6,000 participants from two major clinical trials that showed Plavix significantly reduces the risk of heart attack, stroke, and dying.
"We found the previously reported genetic variants had no effect at all on patient outcomes," Paré says.
These findings were simultaneously published online in The New England Journal of Medicine.